Olivier Soriani
Overview
Explore the profile of Olivier Soriani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
530
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allegrini B, Mignotet M, Rapetti-Mauss R, Borgese F, Soriani O, Guizouarn H
J Biol Chem
. 2024 Dec;
301(2):108114.
PMID: 39716493
KCNN4, a Ca-activated K channel, is involved in various physiological and pathological processes. It is essential for epithelial transport, immune system, and other physiological mechanisms, but its activation is also...
2.
Pasquier C, Guerlais V, Pallez D, Rapetti-Mauss R, Soriani O
Life Sci Alliance
. 2023 Jun;
6(9).
PMID: 37339804
The identification of condition-specific gene sets from transcriptomic experiments is important to reveal regulatory and signaling mechanisms associated with a given cellular response. Statistical methods of differential expression analysis, designed...
3.
Rapetti-Mauss R, Nigri J, Berenguier C, Finetti P, Tubiana S, Labrum B, et al.
Gut
. 2023 Mar;
72(4):722-735.
PMID: 36882214
Objective: Intercellular communication within pancreatic ductal adenocarcinoma (PDAC) dramatically contributes to metastatic processes. The underlying mechanisms are poorly understood, resulting in a lack of targeted therapy to counteract stromal-induced cancer...
4.
Cannone S, Greco M, Carvalho T, Guizouarn H, Soriani O, Di Molfetta D, et al.
Cancers (Basel)
. 2022 Aug;
14(15).
PMID: 35954400
Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest of all cancers, having one of the lowest five-year survival rates. One of its hallmarks is a dense desmoplastic stroma...
5.
Braud V, Cazals F, Duca M, Mus-Veteau I, Pasquier C, Soriani O
Bull Cancer
. 2022 Mar;
109(4):505-509.
PMID: 35277240
No abstract available.
6.
Yamaguchi Y, Allegrini B, Rapetti-Mauss R, Picard V, Garcon L, Kohl P, et al.
Front Physiol
. 2021 Nov;
12:736585.
PMID: 34737711
Hereditary Xerocytosis, a rare hemolytic anemia, is due to gain of function mutations in PIEZO1, a non-selective cation channel activated by mechanical stress. How these PIEZO1 mutations impair channel function...
7.
Rapetti-Mauss R, Berenguier C, Allegrini B, Soriani O
Front Pharmacol
. 2020 Oct;
11:525020.
PMID: 33117152
Increasing evidence point out the important roles of ion channels in the physiopathology of cancers, so that these proteins are now considered as potential new therapeutic targets and biomarkers in...
8.
Potier-Cartereau M, Raoul W, Weber G, Maheo K, Rapetti-Mauss R, Gueguinou M, et al.
Rev Physiol Biochem Pharmacol
. 2020 Aug;
183:157-176.
PMID: 32767122
The intracellular Ca concentration is mainly controlled by Ca channels. These channels form complexes with K channels, which function to amplify Ca flux. In cancer cells, voltage-gated/voltage-dependent Ca channels and...
9.
Martin N, Soriani O, Bernard D
Trends Mol Med
. 2020 Jan;
26(3):243-245.
PMID: 31983612
The identification of senolytics, compounds that eliminate senescent cells, is presently a key priority given their therapeutic promise in cancer and aging-associated diseases. Two recent papers by Triana-Martínez et al....
10.
Soriani O, Kourrich S
Front Neurosci
. 2019 Nov;
13:1186.
PMID: 31780884
The sigma-1 receptor (σ1R) is an endoplasmic reticulum (ER)-resident chaperone protein that acts like an inter-organelle signaling modulator. Among its several functions such as ER lipid metabolisms/transports and indirect regulation...